Trademark: ULTIME 2197130
Word
ULTIME
ID
2197130
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
23 July 2021
Registration Date
23 July 2021
Renewal Date
23 July 2031

Service
AUSTRALIA BIOTECHNOLOGY GROUP

Goods and Services:
Class 5:
Capsules for pharmaceutical purposes; Eucalyptus for pharmaceutical purposes; Eucalyptol for pharmaceutical purposes; Extracts of plants in capsule form (for pharmaceutical use); Extracts of hops for pharmaceutical purposes; Gallic acid for pharmaceutical purposes; Gentian for pharmaceutical purposes; Glucose in the form of pharmaceutical products; Hormone preparations for pharmaceutical use; Homeopathic pharmaceuticals; Hydrolysed starches for pharmaceutical use; Hydrated chloral for pharmaceutical purposes; Magnesia for pharmaceutical purposes; Magnesium salts for pharmaceutical use; Magnesium sulfate for pharmaceutical use; Medical foodstuff additives for pharmaceutical use; Oils for pharmaceutical purposes; Pain killers (pharmaceuticals); Pharmaceutical anticoagulant preparations; Pharmaceutical appetite suppressants; Pharmaceutical compound eye-drops; Pharmaceutical compositions; Pharmaceutical creams; Pharmaceutical cytostatic preparations; Pharmaceutical cytostatic preparations for use in parenteral form; Pharmaceutical drugs; Pharmaceutical drugs being a positive inotropic agent; Pharmaceutical lipsalves; Pharmaceutical medicaments in unit dosage form; Pharmaceutical preparations; Pharmaceutical products; Pharmaceutical products for metabolic disorders; Pharmaceutical products for the central nervous system; Pharmaceutical products for combating heart diseases; Pharmaceutical products for the stimulation of growth; Pharmaceutical products for the treatment of Paget's disease; Pharmaceutical products for the treatment of blood circulation diseases; Pharmaceutical products for the treatment of cardiovascular disorders; Pharmaceutical products for the treatment of dysfunctions of metabolism; Pharmaceutical products for the treatment of gastrointestinal disorders; Pharmaceutical products for the treatment of osteoporosis; Pharmaceutical products in gel form; Pharmaceutical products for use by humans; Pharmaceutical products in the nature of anthelmintic preparations; Pharmaceutical solutions for topical irrigation purposes; Pharmaceutical substances; Pharmaceutical sweets; Pharmaceutical tablets; Pharmaceutical tonic preparations; Phenol for pharmaceutical purposes; Plant extracts for pharmaceutical use; Plant extracts for pharmaceutical purposes; Phosphates for pharmaceutical purposes; Tablets (pharmaceuticals); Yeast extracts for pharmaceutical purposes; Yeast for pharmaceutical purposes; Topical pharmaceutical compositions; Dietetic drinks adapted for medical purposes; Medicated mineral drinks; Medicinal drinks; Babies' food; Baby food; Dietary food preparations for medical use (medical food); Dietetic foods for use in clinical nutrition; Medicated powders; Vitamin drinks; Vitamin tablets; Vitamins; Vitamins for animals; Vitamins for pets; Mineral preparations for use as supplements to drinking water; Antibiotic food supplements for animals; Dietary food supplements; Nutritional drinks being dietary food supplements; Vitamin supplements; Nutritional supplements